Oxidative stress-induced degradation of thioredoxin-1 and apoptosis is inhibited by thioredoxin-1-actin interaction in endothelial cells

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):650-6. doi: 10.1161/ATVBAHA.110.218982. Epub 2011 Jan 6.

Abstract

Objective: Thioredoxin-1 (Trx-1), one important antioxidative enzyme in endothelial cells, is required for apoptosis inhibition. Apoptosis induction is dependent on cytoskeletal changes, which depend on actin rearrangements. Therefore, we wanted to elucidate whether a physical interaction exists between Trx-1 and actin and what the functional consequences are.

Methods and results: Combined immunoprecipitation/mass spectrometry identified actin as a new binding partner for Trx-1. A separate pool of Trx-1 forms a complex with apoptosis signaling kinase 1. Actin is required for stress fiber formation; thus, the interaction of actin with Trx-1 might interfere with this process. Stress fiber formation, which is directly linked to the phosphorylation of focal adhesion kinase (FAK), occurs as early as 1 hour after H(2)O(2) treatment. It is inhibited by Trx-1 overexpression, treatment with exogenous Trx-1, or inhibition of FAK. Prolonged incubation with H(2)O(2) induced stress fiber formation, reduced Trx-1 protein levels, and increased apoptosis. All these processes were inhibited by preincubation with the FAK inhibitor PF573228. On the contrary, incubation with PF573228 1 hour after H(2)O(2) treatment did not block stress fiber formation, degradation of Trx-1, or apoptosis.

Conclusions: These data demonstrate that the actin-Trx-1 complex protects Trx-1 from degradation and, thus, endothelial cells from apoptosis. Reciprocally, Trx-1 prevents stress fiber formation.

MeSH terms

  • Actins / metabolism*
  • Apoptosis* / drug effects
  • Cells, Cultured
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Focal Adhesion Kinase 1 / antagonists & inhibitors
  • Focal Adhesion Kinase 1 / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Immunoprecipitation
  • MAP Kinase Kinase Kinase 5 / metabolism
  • Mass Spectrometry
  • Oxidants / pharmacology
  • Oxidative Stress* / drug effects
  • Phosphorylation
  • Protein Binding
  • Protein Interaction Mapping
  • Protein Kinase Inhibitors / pharmacology
  • Quinolones / pharmacology
  • Stress Fibers / metabolism
  • Sulfones / pharmacology
  • Thioredoxins / genetics
  • Thioredoxins / metabolism*
  • Transfection

Substances

  • 6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-one
  • Actins
  • Oxidants
  • Protein Kinase Inhibitors
  • Quinolones
  • Sulfones
  • TXN protein, human
  • Thioredoxins
  • Hydrogen Peroxide
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • MAP Kinase Kinase Kinase 5
  • MAP3K5 protein, human